Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,400.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 4,025.00p
  • 52 Week Low: 2,300.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 15,926
  • Market Cap: £125.40m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,130,112
Ian James Nicholson 13,000 £312,000
Bruce Hiscock 1,236 £29,664

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £125,271,744
Castlefield Fund Partners Limited 985,000 £23,640,000
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,240,000
Gresham House Asset Management Limited 627,782 £15,066,768
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £14,868,000
Miton Group plc 508,135 £12,195,240
The Diverse Income Trust plc 302,300 £7,255,200
Schroders plc 284,795 £6,835,080
Wasatch Advisors, Inc. 265,000 £6,360,000
Raymond James Wealth Management Limited 263,770 £6,330,480
Canaccord Genuity Group Inc 259,940 £6,238,560
Adrian Williams 253,372 £6,080,928

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,400.00p
Change Today -50.00p
% Change -2.04 %
52 Week High 4,025.00p
52 Week Low 2,300.00p
Volume 15,926
Shares Issued 5.22m
Market Cap £125.40m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 08-Oct-2025

Time Volume / Share Price
16:17 38 @ 2,400.00p
15:38 51 @ 2,377.00p
15:27 175 @ 2,425.00p
14:59 324 @ 2,377.00p
14:52 25 @ 2,377.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page